|
Market Closed -
Bombay S.E.
11:02:28 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4,804.25 INR | -1.77% |
|
-3.43% | +25.06% |
| 09-08 | India's Torrent Gas files updated IPO papers | RE |
| 07-30 | Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 1,827B 19.06B 16.59B 15.67B 14.23B 26.66B 26.77B 187B 72.41B 930B 71.6B 70.01B 2,990B | P/E 2027 * |
71.4x | P/E 2028 * | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1,949B 20.34B 17.7B 16.72B 15.18B 28.44B 28.55B 200B 77.25B 992B 76.38B 74.69B 3,189B | EV / Sales 2027 * |
9.84x | EV / Sales 2028 * | 8.62x |
| Free-Float |
36.58% | Yield 2027 * |
0.68% | Yield 2028 * | 0.79% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| TORNTPHARM | Delayed | |
NSE India S.E.
| TORNTPHARM | Delayed |
Last Transcript: Torrent Pharmaceuticals Limited
| 1 day | -1.77% | ||
| 1 week | -3.43% | ||
| Current month | -3.49% | ||
| 1 month | -4.16% | ||
| 3 months | +8.53% | ||
| 6 months | +14.14% | ||
| Current year | +25.06% |
| 1 week | 4,753.65 |  | 4,950 |
| 1 month | 4,753.65 | | 5,049 |
| Current year | 3,724.1 | | 5,249.95 |
| 1 year | 3,480 | | 5,249.95 |
| 3 years | 1,822.25 | | 5,249.95 |
| 5 years | 1,242.5 | | 5,249.95 |
| 10 years | 571.75 | | 5,249.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 31/07/2025 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 31/08/2018 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 29/07/2014 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 06/03/2019 |
| Director/Board Member | 59 | 28/07/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/11/24 | Buy | Chief Operating Officer | 930,144 | 0.2748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.77% | -3.43% | +32.30% | +154.91% | 19.04B | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | -0.14% | +2.59% | +25.95% | +56.31% | 362.08B | |
| Weighted average by Cap. | -0.05% | +3.06% | +34.83% | +62.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 198B 2.07B 1.8B 1.7B 1.54B 2.89B 2.9B 20.31B 7.85B 101B 7.76B 7.59B 324B | 223B 2.32B 2.02B 1.91B 1.74B 3.25B 3.26B 22.85B 8.83B 113B 8.73B 8.54B 365B |
| Net income | 24.72B 258M 225M 212M 193M 361M 362M 2.53B 980M 12.58B 969M 947M 40.45B | 34.25B 357M 311M 294M 267M 500M 502M 3.51B 1.36B 17.43B 1.34B 1.31B 56.04B |
| Net Debt | 122B 1.27B 1.11B 1.05B 950M 1.78B 1.79B 12.51B 4.83B 62.08B 4.78B 4.67B 200B | 93.6B 976M 850M 803M 729M 1.37B 1.37B 9.6B 3.71B 47.62B 3.67B 3.59B 153B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | ₹4,804.25 | -1.77% | 5,888 |
| 17/09/26 | ₹4,891.00 | +1.41% | 6,250 |
| 16/09/26 | ₹4,823.05 | -0.56% | 50,703 |
| 15/09/26 | ₹4,850.00 | -2.51% | 6,237 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
